Biovista Competitors and Similar CompaniesClear all
Boundless Bio's competitors and similar companies include Curis and Verseau Therapeutics.
 Boundless Bio Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers. |  Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. |  Verseau Therapeutics Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. | |
Founding Date | Founding Date 2019 | Founding Date 2000 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Lexington, US HQ Lexington, US | Locations Bedford, US HQ |
Employees | Employees 2856% decrease | Employees 3144% decrease | Employees 6 |
Financial | |||
Net income | Net income ($58.2m) (FY, 2025) | Net income ($7.6m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 46.4m | Total funding raised N/A | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Curis
HQ
Lexington, US
Employees
31↓ 44% decrease
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
View companyVerseau Therapeutics
HQ
Bedford, US
Employees
6
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.
View company